MK0906 phase III double-blind comparative study - benign prostate hyperplasia.
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Finasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 20 Oct 2009 Actual end date (July 2005) added as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Oct 2006 New trial record.